Latest News

Promising chronic pain drug developed

A recent report indicates that 116-million Americans live with some form of chronic pain. Historically, chemists have developed drugs aimed at just one biological target. Two drugs used together may metabolize differently or present other issues. This new drug, named UMB 425 affects two different opioid receptors, providing diminished tolerance.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Early prosocial behavior good predictor of kids' future

  • Science educators analyze genetics content of Next Generation Science Standards

  • Study of 'senior citizen' marine snails uncovered how nerve cells fail during learning

  • Targeted therapy shows effectiveness against a subtype of the brain tumor medulloblastoma

  • Naturally occurring protein fragment found in the brain inhibits key enzyme implicated in Alzheimer's disease

  • Ongoing recovery efforts take toll on hurricane survivors

  • Climbing a tree can improve cognitive skills, researchers say

  • Socially integrated women have lower suicide risk

  • Key factor for stability of capillaries in brain identified

  • Mechanism behind the lack of effectiveness of certain antagonist drugs discovered

  •